Constance Wilkinson, Member of Epstein Becker Green, will co-present on a webinar on “340B Program and the Proposed Mega-Guidance” on October 22, 2015, from 2:00 – 3:00 p.m. ET.

With recent publication of the long-awaited proposed “Mega-Guidance,” the federal 340B Drug Discount Program (“the 340B Program”) is poised for significant changes. This webinar describes the 340B Program’s historical background, practices, and challenges that resulted in the proposed policies and goals reflected in the Mega-Guidance. In addition to learning about the history of the 340B Program, participants will be educated on how it works—what manufacturers and providers must do to participate in and comply with the Program, how to navigate the 340B website and database maintained by the Health Resources and Services Administration (HRSA), and what specific reforms have been proposed for public comment.

This webinar is free and is being hosted by ACI. To register, please click here.